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Summal~ 
Interferon 3,-inducible protein  10  (IP-10),  a  member of a family of small proinflammatory 
chemotactic polypeptides, is expressed in interferon 3,-stimulated keratinocytes, macrophages, 
fibroblasts, and endothelial cells.  Here we report that IP-10 is also expressed by activated but 
not resting T  hybridoma cells, normal T  cells, and thymocytes. Although resting lymphocytes 
did not synthesize IP-10, surprisingly high levels of IP-10 transcripts were found in lymphoid 
organs (spleen, thymus, and lymph nodes). Thymic and splenic stromal cells were found to express 
constitutively high levels of both IP-10 mRNA and protein, accounting for the high level of 
spontaneous expression in lymphoid tissue. Therefore, in addition to its role as a proinflammatory 
cytokine, IP-10 may participate in T  cell effector function and perhaps T  cell development. 
I 
nducible protein 10 (IP-10) is an early-response gene ex- 
pressed by activated human mononuclear cells, keratino- 
cytes, fibroblasts, and endothelial cells (1, 2). IP-10 belongs 
to a family of genes that encode small peptides involved in 
proinflammatory and chemotactic processes during the im- 
mune response (reviewed in 3, 4). IP-10 was initially described 
as an early, transiently expressed, IFN-3,-inducible gene in 
a histiocytic lymphoma cell line with monocyte characteris- 
tics (1). IP-10 transcripts can also be induced in BALB/c 3T3 
fibroblasts (5) and murine peritoneal macrophages (6, 7). Both 
human IP-10 and the murine homologue (C7 or CRG-2) 
(8,  9)  encode  a  mature  protein  with  a  predicted  Mr  of 
"~10,000  that,  like other members of this gene family, is 
secreted (2).  The secreted product migrates with an Mr of 
6,000-7,000 on SDS-PAGE (2, 10), and it has been suggested 
that posttranslational processing at the NH2 terminus may 
account for the difference between the predicted and the ac- 
tual size (11,  12). 
The functional role of IP-10 has yet to be firmly estab- 
lished. Because of its inducibility by IFN-~/and its homology 
to platelet factor 4  and B-thromboglobulin,  it is generally 
believed that IP-10 is involved in inflammatory responses, per- 
haps as a mediator of IFN-~/effects. Since IP-10 has recently 
been shown to be a chemoattractant for monocytes and T 
C.  R.  Gattass and L.  B. King contributed equally to this paper. 
lymphocytes (13), IP-10 may function to increase local mono- 
nuclear cell infiltration during inflammatory processes such 
as ddayed-type hypersensitivity and contact sensitivity. In ad- 
dition, tumor ceils transfected with an IP-10 expression con- 
struct have been shown to be rejected more efficiently than 
nonsecreting tumors (10),  perhaps by potentiating a T  cell 
response. IP-10 has also been shown to inhibit colony forma- 
tion of bone marrow progenitor cells (11), suggesting its effects 
may be quite pleiotropic. 
During the course of experiments designed to identify T 
cell genes induced by cellular activation, we isolated IP-10 
cDNA from an anti-TCR stimulated T cell hybridoma cDNA 
library. This prompted us to examine normal lymphoid tissues 
for IP-10 expression. 
Materials and Methods 
Cells and Reagents.  2B4.11  is a cytochrome c-specific T cell hy- 
bridoma (14) maintained in RPMI/10% FCS (BioFluids Inc., Rock- 
ville, MD). TEC and TEPI are thymic epithelial cell lines kindly 
provided by Dr. Ada Kruisbeek (Netherlands Cancer Institute, Am- 
sterdam,  The Netherlands) (15). 145-2Cl1(2Cll)  is a hamster 
anti-mouse CD3-e mAb (16), and G7 is a mitogenic rat anti-mouse 
Thy-1  mAb (17). ZnSO4,  cycloheximide  (CHX),  PMA,  iono- 
mycin, and Con A, were obtained from Sigma Chemical Co. (St. 
Louis, MO). Cyclosporin A (CsA) was purchased from Sandoz Phar- 
maceuticals Corp. (East Hanover, NJ) and stored as a stock solu- 
tion in 50% ethanol. 
Preparation ofPlasmid  DNA.  A cDNA done of mouse lP-10, 
CKG-2, was kindly provided by Dr. Joshua Farber (Johns Hopkins 
1373  The Journal of Experimental Medicine ￿9 Volume 179  April 1994  1373-1378 University, Baltimore,  MD). Phsmid DNA was prepared according 
to Maniatis (18). A HindlII/XbaI fragment of this plasmid con- 
raining ,,~851 bp was used as a probe in Northern  blot analysis. 
32P-hbeled probes were prepared by random primer labeling using 
the T7 Quick Prime labeling kit from Pharmacia LKB Biotech- 
nology Inc. (Piscataway,  NJ), according to the manufacturer's in- 
structions. 
Preparation of Stromal Cells.  Stromal cells were prepared by 
crushing thymi or spleens with a syringe plunger and washing the 
remaining  particulate  matter several times to eliminate  as many lym- 
phocytes  as possible. For protein secretion experiments, the stromal 
elements were further treated with coUagenase (0.6 mg/ml in PBS 
with 1% FCS) for 1 h at 37~  The single cell preparations ob- 
tained after such treatments were still 70%-80%  Thy-1  § 
Preparation  of  RNA and Northern  Analysis.  In experiments  with 
2B4.11 cells, 50  x  106 cells were stimulated in Falcon Integrid 
150  x  25 mm tissue culture dishes (model no. 3025; Falcon Lab- 
ware, Becton Dickinson & Co., Oxnard, CA) coated or not with 
purified 2Cll (10 #g/ml in PBS) (19) and in the presence or ab- 
sence of CHX, CsA, or ZnSO4. After the indicated times, cells 
were harvested and total RNA extracted using the RNAzol (Tel- 
Test, Inc., Friendswood, TX) method as per manufacturer's in- 
structions. Both splenocytes and tbymocytes were stimulated in 
dishes coated with 2Cll  or medium containing  the  indicated 
stimulus, harvested after 3 h at 37~  and RNA was extracted as 
above. In the case of normal tissue, isolated material was homo- 
genized (Brinkmann Instruments Co., Westbury, NY) and RNA 
extracted using the RNAzol procedure. Equal amounts of KNA 
(30  #g)  were denatured,  subjected to electrophoresis on a 1% 
agarose-formaldehyde gel,  and blotted  by capillary transfer to 
Hybond-N membranes (Amersham Corp., Arlington Heights, Il- 
linois) (18). The membranes were prehybridized at 42~  in a solu- 
tion containing 50% formamide, 12.5  x  Denhardt's solution, 5 x 
SSC, 0.1% SDS, 0.05 mg/ml denatured salmon sperm DNA, and 
200 #g/m1 yeast RNA. After 4-8 h of prehybridization, a labded 
denatured probe was added and hybridization was carried out for 
another 16-20 h. The blots were generally  washed twice with 2 x 
SSC/0.1% SDS for 10 min at room temperature and three times 
for 20 min at 55~  although similar results were obtained when 
blots were washed at higher stringency (lx  SSC/0.1% SDS at 
65~  The blots were exposed using X-OMAT AK X-ray film 
(Eastman Kodak Co., Rochester, NY) with DuPont Co. (Wil- 
mington, DE) Lightning-Plus intensifying screens at - 70~  Ex- 
pression of GAPDH (kindly provided by Dr. F. Mushinski, Na- 
tional Cancer Institute  [NCI]) was always assessed on the same 
blots as a control for the quantity of mRNA loaded in each lane. 
For the experiments involving CsA, after probing for IP-10, the 
blots were stripped and probed again with IIr2 eDNA (a gift of 
Dr. F. Mushinski, NCI). 
Secretion oflP-lO.  To analyze the secretion of IP-10, cells were 
cultured in serum-free  medium (Hbl; "Centrex  Laboratories, Port- 
land, ME) for 20-24 h at a concentration of 5  x  10  s cells/m1 
(2B4.11) or 2-2.25  x  106/ml (thymocytes and thymic stromal 
cells). Supernatants were concentrated ~10-fold on a Centricon-3 
(Amicon, Danvers, MA) and supematants  dectrophoresed  on a 15% 
Tris-Tricine gel (20). After transfer onto Immobilon-P (Millipore 
Corp., Bedford, MA), the blots were probed with an anti-IP-10 
rabbit antiserum (10), developed with alkaline phosphatase-con- 
jugated donkey anti-rabbit antiserum 0ackson ImmunoResearch 
Laboratories, West Grove, PA), and detected using the chemilumi- 
nescent substrate, Lumiphos-530 (Boehringer Mannheim, Indi- 
anapolis, IN),  as described (21). 
Results 
Induction  and  Regulation  of IP-IO  Expression  in  2134.11 
Cells.  A subtractive hybridization analysis  undertaken to iden- 
tify genes induced during T  call activation led to the isola- 
tion of a eDNA done that was identified as the previously 
characterized  routine  homolog  of  the  IFN-T-inducible 
cytokine, IP-10 (data not shown). Northern blot analysis re- 
vealed that IP-10 mKNA is expressed at very low levels in 
resting routine 2134.11 T hybridoma cells (Fig. 1). Upon stim- 
ulation via the TCK, the level of IP-10  mRNA increased 
within 1 h, continued to rise until 3-4 h after stimulation, 
and then rapidly declined. These kinetics are similar to that 
observed in activated macrophages (6). IP-10 has been shown 
to be a macrophage early response  gene (i.e., its expression 
can be transcriptionally upregulated in the absence of con- 
tinued protein synthesis). To determine if this is true in T 
calls, 2B4.11 cells were stimulated in the presence of the pro- 
tein synthesis inhibitor CHX.  CHX was added to resting 
or stimulated 2B4.11 cells and IP-10 expression  assessed 3 h 
later (Fig. 2 A). The inducible expression  of IP-10 was not 
prevented by CHX: instead, the level ofmRNA was enhanced 
in both nonstimulated and 2Cll-activated cells (compare lanes 
I  and 2 with 5 and 6).  The 3' untranslated region of IP-10 
contains the AUUUA motif thought to bind labile proteins 
that promote message  destabilization (22).  Inhibiting syn- 
thesis of these labile proteins often leads to superinduction 
of short-lived messages  containing this motif. Since CHX 
increases IP-10 transcript levels  in both unstimuhted and stimu- 
lated 2B4.11 calls, these data are consistent with the possi- 
bility that steady state transcript levels are at least partially 
regulated by message  destabilization. 
The T cell hybridoma 2B4.11 undergoes programmed cell 
death when activated  (14, 19). One of the hallmarks of T 
cell apoptosis is the activation of DNA endonucleases  (23), 
and perhaps RNA endonucleases  (24).  Since endonudeases 
may be involved in the destabilization of mKNA containing 
AUUUA motifs (22), we stimulated 2B4.11 cells with 2Cll 
in the presence of inhibitors of apoptosis to see if IP-10 tran- 
script levels would be superinduced. CsA, a potent inhibitor 
of IL-2 and IFN-~/transcription (25) as well as activation- 
induced apoptosis,  did not inhibit the 2Cll-induced increase 
in IP-10 expression (Fig. 2 A), although in the same experi- 
ment IL-2 mKNA induction was completely inhibited (Fig. 
Figure  1.  Kinetics  of IP-10 in- 
duction  in 2134.11. 2134.11 cells  (50 
x 106) were  stimulated  on 2C11- 
coated (10 #g/ml) 150-ram Petri 
dish plates  for 0-6 h. At the indi- 
cated times, cells were harvested 
and total RNA extracted. 30 #g 
of each RNA sample was sub- 
jected to Northern blot analysis 
using an XbaI/HindIII  fragment 
of IP-10 as a probe. GAPDH  was 
used as a control  for R.NA  loading 
(data not shown). 
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duction of  IP-10  by 2B4.11 ceils. (A) 2B4.11 ceils  were 
stimulated for 3 h on phtes that were preciously  treated 
or not with 2Cll (10/xg/ml), 66/~M ZnSO4, 500 
ng/ml CHX (lanes e and  j}, 50 ng/ml CsA, or combi- 
nations of these. 25 #g of total RNA was separated 
in a 1% agarose gd, transferred to nylon membranes 
and probed for IP-10 or GAPDH message. (B) The 
blot shown in  A was stripped and the hnes representing 
2B4.11 ceils  cultured in medium with or without 2Cll 
and with or without CsA  were  reprobed  for  Ib2 
mRNA. 
2 B). CsA actually enhanced IP-10 expression in unstimu- 
lated and 2C11-stimulated 2B4.11 cells, suggesting that CsA 
may function to inhibit the destabilization of IP-10 mRNA, 
either directly via an endonuclease or indirectly by inhibiting 
other proteins involved in the destabilization process. In ad- 
dition, we stimulated 2B4.11 cells in the presence of Zn  2+ , 
an inhibitor of Ca2+/Mg2+-dependent endonucleases  that 
prevents DNA fragmentation in thymocyte nuclei ([23] and 
Yang, Y., and J. D. Ashwell, unpublished observation) and 
2B4.11 cells (Zacharchuk, C., and J. D. Ashwell, unpublished 
observation).  When  added to  resting  2B4.11 cells, Zn  2§ 
caused a small increase in the level of IP-10 mRNA, and no 
enhancement of activation-induced IP-10 expression (Fig. 2). 
Therefore CsA, but not Zn  2+ , augments resting and TCR- 
mediated increases in IP-10 mRNA levels, perhaps by in- 
fluencing message stability. 
Expression of lP-lO in Normal Tissues.  A survey of IP-10 
transcript expression in normal mouse tissues was undertaken. 
A small amount of IP-10 mRNA was detected in kidney and 
lung, and none in heart or brain (Fig. 3), confirming obser- 
vations that constitutive expression of IP-10 in normal tissue 
is generally quite low (26). Unexpectedly, Northern blot anal- 
),sis revealed that IP-10 is constitutively  expressed at high levds 
in lymphoid organs (thymus, lymph node, and spleen) as well 
as in liver. To determine if activated  lymphoid  cells  were respon- 
sible for high levels of IP-10 mRNA, R.NA from isolated 
thymocytes was analyzed for IP-10 expression.  As shown in 
Fig. 4, no IP-10 was detected in resting thymocytes. Stimu- 
lation with Con A did not increase IP-10 mRNA, and PMA 
alone induced only a small amount. Concomitant stimula- 
tion with PMA and the Ca  2  + ionophore ionomycin, or ac- 
tivation with a mitogenic anti-Thy-1 mAb, resulted in large 
increases in IP-10 transcripts. Stimulation with an anti-CD3 
antibody, 2Cll,  also induced IP-10 mRNA at 3 h, but in 
repeated experiments there was too much RNA degradation 
(presumably due to induction of apoptosis) to accurately quan- 
titate the levels (data  not shown). 
Since expression in resting thymocytes seemed unlikely to 
account for the high level of IP-10 transcripts in the thymus, 
thymic stroma was analyzed.  As shown in Fig.  5, the level 
of expression in thymic stroma was as high as that in whole 
thymus (Fig.  5 A).  Two thymic epithelial cell lines,  TEC 
and TEPI, both expressed high levels of IP-10 mRNA (Fig. 
5 B), confirming that thymic epithelial cells are capable of 
expressing IP-10. Similar results were obtained with spleen 
preparations (Fig.  6);  nonactivated splenocytes  did not ex- 
press IL-10, but expression was induced by activation with 
2Cll.  ILNA made from splenic stroma did hybridize with 
Figure 3.  Expression of IP-10 in tissues. Thymus, brain, heart, kidney, 
lung, spleen, lymph node, and liver were homogenized  and total RNA 
extracted. 30/~g of  each RNA was separated on a 1% denaturing  agarose 
gel by electrophoresis, transferred to nylon membranes, and hybridized 
with an XbaI/HindlII IP-10 fragment. 
Figure 4.  Expression of IP-10 
in activated, but not resting, thy- 
mocytes. Thymocytes  (10S/dish) 
were cultured for 3 h with me- 
dium alone;  10/zg/ml G7, 5 ~g/ml 
Con A, 10 ng/ml PMA, or I ng 
PMA plus 0.5/zg/ml ionomycin. 
After stimulation, total RNA was 
made and Northern blot analysis 
performed.  30/zg of each RNA 
sample were loaded in each lane. 
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activated  2B4.11 cells secrete 1P- 
10. 2B4.11 cells were cultured in 
serum-free medium alone or with 
plate-bound  2Cll;  thymocytes 
and thymic stromal cells were cul- 
tured in serum-free medium alone. 
After 20 h, the supematants  were 
concentrated and aliquots removed 
for assay. Secreted products from 
2.5  x  10  s 2B4.11 cells or 1.25  x 
106 thymocytes and thymic stro- 
real cells were assayed  for the pres- 
ence of IP-10. 
Figure  5.  Expression oflP-10 by thymus and stromal cell lines. Whole 
thymus, thymocytes, and thymic stroma were isolated, total RNA extracted 
by the RNAzol procedure, and subjected to Northern blot analysis using 
the IP-10 probe (/1).  TEC and TEPI stromal cell lines were grown in 
RPMI/10%  FCS.  RNA prepared from each cell line (30/zg/lane) was 
used for Northern analysis (B). 
the IP-10 probe, although once again degradation of RNA 
from this source made quantitation difficult.  Together, the 
data indicate that IP-10 is constitutively expressed by thymic 
and splenic stromal cells, and that expression can be induced 
by activation in thymocytes and peripheral T  cells. 
Secretion of  lP-lO by 2B4.11 Cells  and Thymic  Stroma.  The 
ability of different cell populations to secrete IP-10 protein 
was also assessed. Using the antimurine IP-10 antiserum for 
immunoblotting, IP-10 appears as a doublet (10). Consistent 
with  their  respective  IP-10  transcript levels, 2B4.11 cells 
secreted much more IP- 10 when activated by anti-CD3. Like- 
wise, whereas thymic stromal cells produced easily detect- 
able  IP-10  protein,  thymocytes produced very  little  im- 
munoreactive material (Fig. 7). Thus, both activated T cells 
and thymic stromal cells, in the absence of overt stimulation, 
synthesize and secrete the IP-10 chemokine. 
Figure  6.  Expression  of IP-IO 
transcripts  by  splenocytes  and 
splenic  stroma.  Whole  spleen, 
splenocytes,  and  splenic  stroma 
were  isolated,  total  RNA  ex- 
tr~t~ by the P~Azol p~lure, 
and subjected  to Northern blot 
analysis using  the  IP-10 cDNA 
probe. 
Discussion 
IP-10  is a member of a family of proinflammatory and 
chemotactic cytokines expressed by activated macrophages, 
fibroblasts, keratinocytes, and endothelial cells (1, 5-8). The 
results in this paper demonstrate that IP-10 is also expressed 
by activated  T  cells. Although IP-10 was first described as 
an IFN-3,-induced monokine, it is unlikely that IFN-7 is 
involved in 2Cll-induced expression of IP-10 in T cells. First, 
IP-10 expression is rapid (within 1-2 h). Second, if expres- 
sion of IP-10  transcripts depended upon the  synthesis  of 
IFN-% it would be expected that inhibition of protein syn- 
thesis would inhibit IP-10 expression;  CHX actually led to 
increased accumulation of IP-10 transcripts.  Third, no IFN-3, 
activity was detected in the supernatants of 2Cll-activated 
2B4.11 calls (data not shown), indicating that activation of 
2B4 neither induces IFN-7 synthesis nor causes the release 
of presynthesized cytokine. Therefore, it seems likdy that 
activation-induced  expression of IP-10 is a direct consequence 
of TCR-mediated activation rather than secondary to a secreted 
lymphokine. 
Like macrophages, expression of IP-10 in T cells increases 
rapidly after stimulation, reaches a maximum in 3-4 h, then 
declines. This transient expression has been attributed to the 
presence of an AUUUA motif in the 3' untranslated region 
of the transcript that leads to message destabilization  (27). 
Rapid degradation of RNAs bearing such sequences is due 
to recognition of this specific region by RNA-binding pro- 
teins (28, 29) that either target the RNA for destabilization 
or lead directly to its destruction. CHX not only blocks degra- 
dation conferred by these AU-rich sequences, but can cause 
superinduction of gene expression (22).  In agreement with 
these observations,  treatment of 2B4.11 with CHX results 
in increased expression  of IP-10 in both unstimulated and 
stimulated cells. 
Although induction of IP-10 expression  in 2B4.11 is in- 
creased by TCR-dependent activation, CsA, a potent inhib- 
itor of many activation responses in T cells, actually increases 
IP-10  mRNA under the same conditions that completely 
inhibit the induction of IL-2 mRNA. The immtmosuppressive 
effect of CsA on T call proliferation is via a Ca2+-sensitive 
pathway involving calcineurin, a calmodulin-dependent  pro- 
tein phosphatase (30, 31). Our results suggest that IP-10 ex- 
pression in 2Cll-stimulated cells is not dependent on this 
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stimulated and stimulated cells, it is possible that the expres- 
sion of a protein involved in message destabilization  is in- 
hibited by CsA. It should be noted that the opposite result 
(inhibition of IP-10 expression by CsA) was observed by an- 
other group using PHA-activated human T lymphocytes (32). 
The reason for the discrepancy between the data is not known, 
but could be due to differences in the source and purity of 
the cells (a routine T cell hybridoma vs. semipurified human 
peripheral blood T  cells), the stimulus (anti-CD3 vs. PHA 
or PHA plus P/VIA), or the duration of stimulation (3 vs. 12 h). 
Constitutive expression of IP-10 in tissues such as liver, 
spleen, lymph node, and thymus was unexpected. It is pos- 
sible that the presence of IP-10 transcripts in liver is due to 
the presence of activated macrophages.  The other nonlym- 
phoid tissues examined,  lung,  heart,  kidney and brain,  ex- 
press few if any IP-10 transcripts.  Despite its inducibility upon 
activation,  the constitutive expression of IP-10 observed in 
whole thymus does not seem to be due to the presence of 
activated thymocytes, as isolated thymocytes do not have de- 
tectable levels of IP-10 mRNA. The majority of the consti- 
tutively expressed IP-10 in thymus seems to be due to epi- 
thdial cells, as both isolated thymic stromal cells and thymic 
epithdial cell lines spontaneously express high levels of IP- 
10.  These data suggest  that  the thymic  stromal calls con- 
stitutively express IP-10 or are induced to do so under normal 
physiological conditions. Similar results were obtained when 
splenocytes were isolated from splenic stroma. Although the 
physiological role of IP-10 remains to be determined, it prob- 
ably partidpates in inflammatory processes and may be a medi- 
ator of macrophage function (33, 34).  Furthermore,  IP-10 
has recently been shown to be a chemoattractant  for mono- 
cytes and activated T cells (13). It is possible that in addition 
to its participation in macrophage function, IP-10 could func- 
tion in the thymus and participate  in T  cell-mediated im- 
mune responses. 
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